Pliant Therapeutics annual net debt
2020
2021
2022
2023
2024
2025
Pliant Therapeutics Net Debt Growth & History (PLRX)
Pliant Therapeutics's net debt was −$16.3M for fiscal 2025.
View full Pliant Therapeutics company overviewPliant Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$16.3M | −$5.3M | — |
| 2024 | 2024-12-31 | −$11.0M | $40.9M | — |
| 2023 | 2023-12-31 | −$51.9M | −$34.0M | — |
| 2022 | 2022-12-31 | −$17.9M | $26.6M | — |
| 2021 | 2021-12-31 | −$44.5M | $6.4M | — |
| 2020 | 2020-12-31 | −$50.9M | — | — |
Pliant Therapeutics quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.9M | $30.3M | — |
| Q1 2026 | 2026-03-31 | $6.6M | $38.4M | — |
| Q4 2025 | 2025-12-31 | −$16.3M | −$5.3M | — |
| Q3 2025 | 2025-09-30 | −$33.9M | −$14.5M | — |
| Q2 2025 | 2025-06-30 | −$26.4M | −$6.3M | — |
| Q1 2025 | 2025-03-31 | −$31.8M | $27.9M | — |
| Q4 2024 | 2024-12-31 | −$11.0M | $40.9M | — |
| Q3 2024 | 2024-09-30 | −$19.4M | $26.2M | — |
| Q2 2024 | 2024-06-30 | −$20.2M | $20.3M | — |
| Q1 2024 | 2024-03-31 | −$59.6M | $27.7M | — |
| Q4 2023 | 2023-12-31 | −$51.9M | −$34.0M | — |
| Q3 2023 | 2023-09-30 | −$45.6M | −$17.7M | — |
| Q2 2023 | 2023-06-30 | −$40.4M | −$31.7M | — |
| Q1 2023 | 2023-03-31 | −$87.3M | −$61.7M | — |
| Q4 2022 | 2022-12-31 | −$17.9M | $26.6M | — |
| Q3 2022 | 2022-09-30 | −$27.9M | $17.3M | — |
| Q2 2022 | 2022-06-30 | −$8.8M | $26.4M | — |
| Q1 2022 | 2022-03-31 | −$25.6M | $25.2M | — |
| Q4 2021 | 2021-12-31 | −$44.5M | $6.4M | — |
| Q3 2021 | 2021-09-30 | −$45.2M | — | — |
| Q2 2021 | 2021-06-30 | −$35.2M | — | — |
| Q1 2021 | 2021-03-31 | −$50.8M | — | — |
| Q4 2020 | 2020-12-31 | −$50.9M | — | — |
Pliant Therapeutics net debt trends
Over the last five fiscal years, Pliant Therapeutics's net debt increased from −$50.9M to −$16.3M, a change of $34.5M. The latest reported quarter, Q2 2026, shows $3.9M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Pliant Therapeutics source filings ↗